NOTE 8 - STOCK-BASED COMPENSATION

Our stock-based compensation programs are long-term retention awards that are intended to attract, retain, and provide incentives for employees, officers and directors, and to align stockholder and employee interest. We utilize grants of both stock options and warrants and restricted stock to achieve those goals.

Summary of Stock Options and Warrants

During the nine months ending April 30, 2025, we recorded no compensation expense related to stock options and warrants. During the nine months ending April 30, 2024, we recorded $76,482 of compensation expense related to stock options and warrants. We granted no stock options or warrants during the nine months ending April 30, 2025 or 2024.

The following table summarizes our options and equity classified warrant activity for the nine months ending April 30, 2025 and fiscal year ended July 31, 2024:

 SCHEDULE OF OPTIONS AND WARRANTS ACTIVITY

Summary of Restricted Stock Grants

During the nine months ending April 30, 2025, and 2024, we recorded compensation expense related to unvested restricted stock grants of $363,392 and $27,714, respectively. The grant date fair value of restricted stock awards during the nine months ended April 30, 2025, was $2,219,388. Additionally, the Company estimated a 25% discount to market to reflect the legal restrictions preventing the securities from being sold on the OTC market until they are registered or deemed exempt from registration

The following table summarizes our restricted stock activity for the nine months ending April 30, 2025, and fiscal year ended July 31, 2024:

 SCHEDULE OF RESTRICTED STOCK ACTIVITY